Logan Capital Management Inc. Raises Position in Teleflex Incorporated (NYSE:TFX)

Logan Capital Management Inc. grew its position in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 35.7% during the fourth quarter, Holdings Channel reports. The fund owned 950 shares of the medical technology company’s stock after purchasing an additional 250 shares during the period. Logan Capital Management Inc.’s holdings in Teleflex were worth $237,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Covestor Ltd boosted its holdings in Teleflex by 305.6% in the third quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 110 shares in the last quarter. Lindbrook Capital LLC raised its position in shares of Teleflex by 75.3% in the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 58 shares during the last quarter. Massmutual Trust Co. FSB ADV boosted its stake in Teleflex by 418.5% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock worth $35,000 after purchasing an additional 113 shares in the last quarter. Janiczek Wealth Management LLC grew its position in Teleflex by 227.1% during the 4th quarter. Janiczek Wealth Management LLC now owns 157 shares of the medical technology company’s stock valued at $39,000 after purchasing an additional 109 shares during the last quarter. Finally, Cary Street Partners Investment Advisory LLC increased its stake in Teleflex by 1,333.3% during the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 215 shares of the medical technology company’s stock valued at $42,000 after purchasing an additional 200 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 2.6 %

NYSE TFX opened at $207.09 on Tuesday. The company has a current ratio of 2.51, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $262.97. The stock’s 50 day moving average is $210.40 and its 200 day moving average is $228.30. The stock has a market cap of $9.75 billion, a PE ratio of 33.24, a P/E/G ratio of 2.06 and a beta of 1.16.

Teleflex (NYSE:TFXGet Free Report) last posted its earnings results on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.14. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The company had revenue of $737.80 million during the quarter, compared to analysts’ expectations of $726.85 million. During the same period last year, the company posted $3.09 earnings per share. Teleflex’s quarterly revenue was up 3.8% on a year-over-year basis. Research analysts predict that Teleflex Incorporated will post 13.75 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Wednesday, May 15th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.66%. The ex-dividend date is Tuesday, May 14th. Teleflex’s dividend payout ratio is presently 21.83%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on TFX shares. JMP Securities reiterated a “market outperform” rating and issued a $285.00 target price on shares of Teleflex in a research note on Friday, February 23rd. Truist Financial decreased their price target on Teleflex from $240.00 to $219.00 and set a “hold” rating for the company in a research note on Friday, May 3rd. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. Royal Bank of Canada reduced their price target on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research report on Friday, February 23rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Friday, May 3rd. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $257.29.

Get Our Latest Analysis on Teleflex

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Further Reading

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.